Apricus Biosciences (NASDAQ:APRI)
CAPS Rating:
A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.
A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.
Recs
At present most players of APRI stock buy and then sell almost on a daily basis.The company should convince investment groups that future earnings should enable them to carry the price to $5.00 ..